The link between childhood trauma and dissociation in frequent users of classic psychedelics and dissociatives
Sascha Thal, J. Daniels, Henrik Jungaberle
Journal of Substance Use May 21, 2019 DOI: 10.1080/14659891.2019.1614234 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 297 |
| Population | Online self-report participants, 80.2% active substance users |
| Citations | 11 |
| Key findings | Substance use does not moderate the link between childhood trauma and depersonalization severity. |
Abstract
ABSTRACT
Background: Childhood trauma severity is associated with the level of subsequent substance use as well as with the self-reported severity of dissociation. Classic psychedelics and dissociatives target neurotransmitter systems thought to be involved in the onset of dissociative symptoms and may evoke severe and long-lasting symptoms of depersonalization in some users. However, it is currently unclear whether drug use puts people with a history of childhood trauma at higher risk of developing dissociative symptoms.
Objectives: The current study investigates whether the one-year prevalence of substance use significantly moderates the link between childhood trauma and the severity of depersonalization.
Methods: Participants (n = 297, of which 80.2% were active users) filled out an online self-report questionnaire including the Childhood Trauma Questionnaire (CTQ), the Cambridge Depersonalisation Scale (CDS), and information about their substance use.
Results: Results indicate that childhood trauma and substance use are significant individual predictors of dissociation scores in this sample, but no moderation of substance use on the link between childhood trauma and depersonalization was established.
Conclusions: It is hypothesized that the quality (particularly the context) of the experience of substance use rather than the sheer quantity may be responsible for the manifestation of depersonalization.
Citations in the library
Cited by 9
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms Pharmacological Reviews December 16, 2020
- Extended difficulties following the use of psychedelic drugs: A mixed methods study PLoS One October 24, 2023
- Ceremonial Ayahuasca in Amazonian Retreats—Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study Frontiers in Psychiatry June 9, 2021
- Personality traits explain the relationship between psychedelic use and less depression in a comparative study. Scientific Reports May 3, 2024
- Recalled childhood trauma and post-psychedelic trajectories of change in a mixed-methods study Scientific Reports November 27, 2025
and 4 more in the library
Cites 24
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial American Journal of Psychiatry August 28, 2013
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Frontiers in Pharmacology January 17, 2018
- Psychedelics and the essential importance of context. Journal of Psychopharmacology February 15, 2018
- Ketamine use: a review Addiction July 21, 2011
and 19 more in the library